Carl A. Ascoli , PhD
Carl A. Ascoli graduated from the University of Medicine and Dentistry of New Jersey in 1988. Working with Dr. Gerd Maul at the Wistar Institute, he identified a novel nuclear structure called PML bodies which serve as a storage depot for various regulatory proteins. He is the Chief Science Officer for Rockland Immunochemicals and has more than 30 years of academic and industrial expertise in virology, immunology, host-agent interaction, autoimmune diseases, cancer biology, antibody production and engineering, protein purification and recombinant technology.
Localization of HDAC1 Using Super-Resolution STED Microscopy
Here we show staining of HDAC1 in cancer tissue and epidermoid carcinoma cells. These results clearly show that the use of appropriate validated antibodies and STED microscopy are important tools to…Read article
Subcellular Localization of AKT and Tubulin using Super-Resolution Microscopy
Stimulated Emission Depletion microscopy, or STED nanoscopy, is a technique that uses the non-linear de-excitation of fluorescent dyes to overcome the resolution limit imposed by diffraction…Read article